Updates are available Correction dated 2018-04-01
Click to view Correction: https://doi.org/10.1038/nm0418-525e
-
Authors
Morton, Nicholas M
Beltram, Jasmina
Carter, Roderick N
Michailidou, Zoi
Gorjanc, Gregor
McFadden, Clare
Barrios-Llerena, Martin E
Rodriguez-Cuenca, Sergio
Gibbins, Matthew T G
Aird, Rhona E
Moreno-Navarrete, José Maria
Munger, Steven C https://orcid.org/0000-0002-8458-1871
Svenson, Karen L
Gastaldello, Annalisa
Ramage, Lynne
Naredo, Gregorio
Zeyda, Maximilian
Wang, Zhao V
Howie, Alexander F
Saari, Aila
Sipilä, Petra
Stulnig, Thomas M
Gudnason, Vilmundur
Kenyon, Christopher J
Seckl, Jonathan R
Walker, Brian R
Webster, Scott P
Dunbar, Donald R
Churchill, Gary A
Vidal-Puig, Antonio
Fernandez-Real, José Manuel
Emilsson, Valur
Horvat, Simon
- License Information
-
More Information
Article History
Received: 19 December 2015
Accepted: 29 April 2016
First Online: 6 June 2016
Change Date: 7 March 2018
Change Type: Corrigendum
Change Details: In the version of this article initially published, the colors of the lines were switched in the graph that shows the glucose infusion rates for wild-type mice and Adipoq-Tst transgenic mice in Figure 3b. The top line should be purple, and the bottom line should be black. The error has been corrected in the HTML and PDF versions of the article.
Change Date: 1 April 2018
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/nm0418-525e
Competing interests
: N.M.M. and S.P.W. hold a target patent (WO2012/104589) for TST in weight-related disorders.
